Do angiotensin-converting enzyme inhibitors reduce MACE in older adults with type 2 diabetes mellitus compared to angiotensin II receptor blockers?
In older patients with type 2 diabetes mellitus, initiating ACEIs may offer a trend toward lower MACE risk compared to ARBs.
Among older patients with T2DM, the initiation of ACEIs was associated with a trend toward lower risk of MACE compared to ARBs, implying the potential cardiovascular benefits of ACEIs in this population.
Zeng et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: